- Home
- CBFV vs ENTA Comparison
CBFV vs ENTA Comparison
Compare CBFV & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- ENTA
- Stock Information
- Founded
- CBFV 1901
- ENTA 1995
- Country
- CBFV United States
- ENTA United States
- Employees
- CBFV N/A
- ENTA N/A
- Industry
- CBFV Major Banks
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- ENTA Health Care
- Exchange
- CBFV Nasdaq
- ENTA Nasdaq
- Market Cap
- CBFV 153.2M
- ENTA 164.6M
- IPO Year
- CBFV N/A
- ENTA 2013
- Fundamental
- Price
- CBFV $32.89
- ENTA $8.53
- Analyst Decision
- CBFV Buy
- ENTA Strong Buy
- Analyst Count
- CBFV 2
- ENTA 4
- Target Price
- CBFV $35.50
- ENTA $20.75
- AVG Volume (30 Days)
- CBFV 10.5K
- ENTA 152.0K
- Earning Date
- CBFV 10-24-2025
- ENTA 08-11-2025
- Dividend Yield
- CBFV 3.04%
- ENTA N/A
- EPS Growth
- CBFV N/A
- ENTA N/A
- EPS
- CBFV 2.15
- ENTA N/A
- Revenue
- CBFV $50,822,000.00
- ENTA $64,806,000.00
- Revenue This Year
- CBFV $9.91
- ENTA N/A
- Revenue Next Year
- CBFV $8.77
- ENTA $1.65
- P/E Ratio
- CBFV $15.32
- ENTA N/A
- Revenue Growth
- CBFV N/A
- ENTA N/A
- 52 Week Low
- CBFV $25.31
- ENTA $4.09
- 52 Week High
- CBFV $33.98
- ENTA $13.43
- Technical
- Relative Strength Index (RSI)
- CBFV 62.01
- ENTA 60.41
- Support Level
- CBFV $30.06
- ENTA $8.47
- Resistance Level
- CBFV $32.94
- ENTA $9.09
- Average True Range (ATR)
- CBFV 0.88
- ENTA 0.53
- MACD
- CBFV 0.01
- ENTA 0.10
- Stochastic Oscillator
- CBFV 96.33
- ENTA 78.79
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.